1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring STAG2 mutations
(
- Contribution to journal › Letter
- 2020
-
Mark
Efficient and nontoxic biomolecule delivery to primary human hematopoietic stem cells using nanostraws
2020) In Proceedings of the National Academy of Sciences of the United States of America 117(35). p.21267-21273(
- Contribution to journal › Article
-
Mark
Combined lentiviral- and RNA-mediated CRISPR/Cas9 delivery for efficient and traceable gene editing in human hematopoietic stem and progenitor cells
(
- Contribution to journal › Article